1239908-20-3 Ixazomib citrate
Nome del prodotto |
Ixazomib citrate |
Nome inglese |
Ixazomib citrate; IXAZOMIB; IXAZOMIB CITRATE; 2,2'-(2-(1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-5-oxo-1,3,2-dioxaborolane-4,4-diyl)diacetic acid; 2-[(1R)-1-[[2-[(2,5-Dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diacetic acid; (R)-2,2'-(2-(1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-5-oxo-1,3,2-dioxaborolane-4,4-diyl)diacetic acid; 2-[4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolan-4-yl]acetic acid |
Formula molecolare |
C20H23BCl2N2O9 |
Peso Molecolare |
517.12 |
Numero CAS |
1239908-20-3 |
EINECS |
C20H23BCl2N2O9 |
Struttura molecolare |
|
Densità |
1.47±0.1 g/cm3(Predicted) |
Simboli di pericolo |
|
Codici di Rischio |
|
Sicurezza Descrizione |
|
|